Immunology

Official Council of Pharmacists Recalls Aemps Review of Nolotil Reactions and Lawsuit Against Ministry of Health

by
Official Council of Pharmacists Recalls Aemps Review of Nolotil Reactions and Lawsuit Against Ministry of Health

The Official Council of Official Colleges of Pharmacists has recalled through an official note that the Spanish Agency for Medicines and Health Products (Aemps) already reviewed the possible reactions associated with the active ingredient metanizol (Nolotil) in 2018. “on the occasion of the notification to the Spanish Pharmacovigilance System of cases of agranulocytosis, particularly in … Read more

XX International Balmis Knows Vaccine Update Conference in Almería: Advancements in Cancer Vaccines and Lessons from COVID-19

by
XX International Balmis Knows Vaccine Update Conference in Almería: Advancements in Cancer Vaccines and Lessons from COVID-19

Almería hosts this week the XX International Balmis Knows Vaccine Update Conference. It is one of the most prestigious and longest-running congresses on vaccinology on the international scene. The meeting, organized by the Institute Balmis de Vaccines and the Official College of Physicians of Almeríawill take place on October 26 and 27 and will dedicate … Read more

“First Loophole-Free Bell Experiment Confirms True Quantum Correlations”

by

Nature highlight May 11, 2023 Nature 6177960 The Bell inequality has helped shed light on the structure of correlations allowed by quantum mechanics and what this theory of physics says about the world. Experimental verification of the Bell inequality is also of practical importance, as it allows confirmation of the existence of true quantum correlations … Read more

“University of Missouri Researchers Discover Critical Protein in COVID-19 Spread”

by
“University of Missouri Researchers Discover Critical Protein in COVID-19 Spread”

Researchers at the University of Missouri have identified a crucial protein, known as the occludin protein, inside the human body that plays a critical role in the transmission of the COVID-19 virus from cell to cell after infection. The finding provides new insight into how the virus spreads throughout cells and presents an opportunity for … Read more

UC Davis Health researchers use CAR T-cell therapy in clinical trial to cure HIV, with no adverse events observed so far.

by
UC Davis Health researchers use CAR T-cell therapy in clinical trial to cure HIV, with no adverse events observed so far.

The medical field has been seeking a cure for Human Immunodeficiency Virus (HIV) for years, and now a potential solution is making strides. Researchers have begun a clinical trial using CAR T cell therapy to attempt to cure HIV. This innovative approach is the first of its kind and offers hope to the millions of … Read more

“Joonyoung Koh, Winner of Yuhan Medical Award Young Medical Scientist Award for Discovering New Cells Operating between Innate and Adaptive Immunity”

by
“Joonyoung Koh, Winner of Yuhan Medical Award Young Medical Scientist Award for Discovering New Cells Operating between Innate and Adaptive Immunity”

[젊은의학자상] Joonyoung Koh, Senior Researcher, Genome Insight Technology Identification of new cells operating at the boundary between innate and adaptive immunity “I will try to succeed as a scholar who shines light for my juniors” “Every day as a basic researcher is like walking towards a lighthouse that is lit in the distance. I think … Read more

The National Institute of Allergy and Infectious Diseases co-hosted a workshop on mucosal vaccines for COVID-19, with researchers emphasizing the need for improvement. No COVID-19 mucosal vaccines have been authorized for use in the US or Europe, but at least 44 are in preclinical development. The workshop concluded that research into mucosal vaccine development is a priority, and could lead to improved vaccines for other diseases.

by
The National Institute of Allergy and Infectious Diseases co-hosted a workshop on mucosal vaccines for COVID-19, with researchers emphasizing the need for improvement. No COVID-19 mucosal vaccines have been authorized for use in the US or Europe, but at least 44 are in preclinical development. The workshop concluded that research into mucosal vaccine development is a priority, and could lead to improved vaccines for other diseases.

The COVID-19 pandemic has had a profound impact on the world, affecting every aspect of life, from work to travel, education to healthcare. While several vaccines have been developed and authorized for emergency use, the race to produce a more effective and convenient vaccine continues. One promising approach is the mucosal COVID-19 vaccine. Unlike traditional … Read more

The National Institute of Allergy and Infectious Diseases hosted a virtual workshop on developing mucosal vaccines for COVID-19, highlighting challenges and opportunities.

by
The National Institute of Allergy and Infectious Diseases hosted a virtual workshop on developing mucosal vaccines for COVID-19, highlighting challenges and opportunities.

Since the onset of the COVID-19 pandemic, scientists worldwide have been tirelessly working on the development of vaccines to curb the spread of the virus. While several vaccines have been developed and authorized for use, there is still a need to explore more efficient and effective ways to combat the virus. One promising approach that … Read more

New research identifies pathways to reducing multi-organ injury caused by COVID-19 cytokine storms and the possibility of specific dual-pathway treatments.

by
New research identifies pathways to reducing multi-organ injury caused by COVID-19 cytokine storms and the possibility of specific dual-pathway treatments.

The COVID-19 pandemic has brought the world to a standstill, and as scientists and medical professionals continue to race against time to find a cure or vaccine, we are learning more about the virus with every passing day. One of the most devastating consequences of the viral infection is the development of cytokine storms, which … Read more

Scientists at Washington University School of Medicine have developed a vaccine against norovirus by piggybacking on vaccines for rotavirus. The researchers added a protein from a strain of norovirus to a harmless strain of rotavirus. Mice that received the experimental vaccine produced neutralising antibodies against both viruses, leading to hopes that the breakthrough could allow for the distribution of a bivalent vaccine to protect against both stomach bugs. The next step will be to find out whether the vaccine works in preventing sickness and death due to norovirus.

by
Scientists at Washington University School of Medicine have developed a vaccine against norovirus by piggybacking on vaccines for rotavirus. The researchers added a protein from a strain of norovirus to a harmless strain of rotavirus. Mice that received the experimental vaccine produced neutralising antibodies against both viruses, leading to hopes that the breakthrough could allow for the distribution of a bivalent vaccine to protect against both stomach bugs. The next step will be to find out whether the vaccine works in preventing sickness and death due to norovirus.

Norovirus, also known as the “winter vomiting bug,” is the leading cause of foodborne illness in the world, affecting millions of people annually. With its highly contagious nature, norovirus can easily spread through contaminated food and water, as well as person-to-person contact. In recent years, outbreaks of norovirus have increasingly become a public health concern, … Read more